搜尋結果
CSPC PHARMA's US Clinical Trial Application for Highly Selective MAT2A Inhibitor Approved
AASTOCKS.com· 10 小時前AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities ...
The Best Hoka Shoes For Running: Your Ultimate Guide For 2024
Forbes· 4 日前In our estimation, there are more people who run in Hokas than those who don’t: The brand is known for its plush support ...
US Anti-Doping Agency calls for Wada overhaul, probe into China swim doping
South China Morning Post· 3 日前“The selective and self-serving application of the rules we heard about yesterday destroys ...
The Story Behind The FAFSA Failure
Forbes· 14 小時前What I learned from Lou’s obituary and the many ensuing tributes is that he seemed to enjoy his ...
Why Cornell’s New SAT Policy Is More Complex Than Other Ivies
Forbes· 4 日前After several Ivy League schools announced their return to standardized testing, Cornell has ...
Steer clear of Apple ahead of earnings, tech investor Dan Niles says
CNBC· 4 日前Things are not looking up for Apple ahead of its fiscal second-quarter earnings, according to tech investor Dan Niles. Apple ...
Startups Weekly: Is the wind going out of the AI sails?
TechCrunch· 7 日前Despite this general downturn, certain segments like generative AI continue to attract ...
Here are the top 10 smartest cities in the world — and none are in the U.S.
CNBC· 5 日前The 2024 Smart City Index, by IMD World Competitiveness Center and the World Smart Sustainable ...
Council Post: How To Successfully Enter A New Market With Influencer Marketing
Forbes· 5 日前In recent years, businesses have increasingly adopted influencer marketing, a form of ...
Spain's Iberdrola, Norway wealth fund expand renewables partnership
Reuters· 1 日前, opens new tab and Norway's $1.6 trillion sovereign wealth fund are building up on their ...